Analyst Ratings For NASDAQ:TPIV – TapImmune (NASDAQ:TPIV)
Today, NASDAQ:TPIV – TapImmune (NASDAQ:TPIV) stock received an upgrade by WBB Securities from Speculative Buy ➝ Buy with a price target of $5.00.
Some recent analyst ratings include
- 5/30/2018-WBB Securities Upgrade from a “Speculative Buy ➝ Buy” rating to a “” rating.
Recent Insider Trading Activity For NASDAQ:TPIV – TapImmune (NASDAQ:TPIV)
NASDAQ:TPIV – TapImmune (NASDAQ:TPIV) has insider ownership of 3.30% and institutional ownership of 3.19%.
- On 5/14/2018 Eastern Capital Ltd, Major Shareholder, bought 1,300,000 with an average share price of $2.40 per share and the total transaction amounting to $3,120,000.00.
Recent Trading Activity for NASDAQ:TPIV – TapImmune (NASDAQ:TPIV)
Shares of NASDAQ:TPIV – TapImmune closed the previous trading session at 4.95 up +0.85 20.63% with 5.199999809265137 shares trading hands.